Aldonist 25 mg (Tablet)
Unit Price: ৳ 45.00 (3 x 10: ৳ 1,350.00)
Strip Price: ৳ 450.00
Medicine Details
Category | Details |
---|---|
Generic | Eplerenone |
Company | Unimed unihealth pharmaceuticals ltd |
Also available as |
Indications
- Congestive heart failure after an acute myocardial infarction
- Hypertension
Pharmacology
Eplerenone selectively binds to the mineralocorticoid receptor and blocks the binding of aldosterone, a key component in the renin-angiotensin-aldosterone-system.
Dosage & Administration
- Congestive Heart Failure after an acute Myocardial Infarction:
- Recommended dose of 50 mg once daily
- May be initiated at 25 mg once daily and titrated to 50 mg once daily
- Hypertension:
- Starting dose of 50 mg once daily, may increase to 50 mg twice daily if needed
Interaction
May increase risk of hyperkalaemia with ACE inhibitors and/or angiotension receptor blocker, ciclosporin, tacrolimus, trimethoprim. May reduce antihypertensive effect with NSAIDs, glucocorticoids, tetracosactide.
Contraindications
- Hyperkalaemia
- Severe renal impairment
- Severe hepatic impairment
- Concomitant use with potent CYP3A4 inhibitors
- Potassium-sparing diuretics
Side Effects
- Headache
- Dizziness
- Diarrhea
- Stomach pain
- Nausea
- Cough
- Flu-like symptoms
- Symptoms of a serious allergic reaction
Pregnancy & Lactation
- Pregnancy: Eplerenone should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus
- Lactation: The concentration of Eplerenone in human breast milk after oral administration is unknown
Precautions & Warnings
Use with caution in hyperkalemia, severe kidney disease, diabetic patients with congestive heart failure after an acute myocardial infarction including those with proteinuria
Use in Special Populations
- Pediatric use: Safety and effectiveness not established in pediatric patients
- Geriatric use: No differences in overall incidence of effectivity or safety observed in elderly patients
Overdose Effects
- Symptoms:
- Hyperkalaemia
- Hypotension
- Management: Symptomatic and supportive treatment. Administer activated charcoal. Initiate standard therapy for hyperkalaemia.
Therapeutic Class
- Potassium-sparing diuretics
- Aldosterone antagonists
Storage Conditions
Store below 30°C in a cool and dry place, protected from light and moisture. Keep out of children’s reach